Project Details
| Status | Active |
|---|---|
| Effective start/end date | 06/7/24 → 06/30/27 |
Funding
- Novartis Pharmaceuticals Corporation: $32,425.00
A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established
- Cimato, Thomas (PI)
Project: Research